Clinical Trial Update: Biodistribution of [11C]Acetoacetate/[18F]Fluorodeoxyglucose in Subjects With Risk Factors for Alzheimer's Disease [NA]

View source ↗

Summary

A completed clinical trial evaluating the biodistribution of imaging tracers [11C]Acetoacetate and [18F]Fluorodeoxyglucose in individuals with Mild Cognitive Im…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• [11C]Acetoacetate
• [18F]Fluorodeoxyglucose (2-deoxy-2-[18F]fluoro-D-glucose)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Mild Cognitive Impairment | NA | Status: COMPLETED